Acacia Diversified Holdings, Inc. Stock Other OTC
Equities
ACCA
US00389L1044
Pharmaceuticals
Sales 2018 | 415K 566K | Sales 2019 | 519K 708K | Capitalization | 3.9M 5.32M |
---|---|---|---|---|---|
Net income 2018 | -1M -1.36M | Net income 2019 | -1M -1.36M | EV / Sales 2018 | 11.4 x |
Net Debt 2018 | 1.04M 1.42M | Net Debt 2019 | 1.23M 1.68M | EV / Sales 2019 | 9.9 x |
P/E ratio 2018 |
-1.95
x | P/E ratio 2019 |
-1.92
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 96.32% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director/Board Member | 51 | 20-03-30 | |
Lisa Smith
SEC | Corporate Secretary | - | 17-03-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 51 | 20-03-30 |
1st Jan change | Capi. | |
---|---|---|
+42.64% | 6.28B | |
-15.52% | 4.51B | |
+8.35% | 3.35B | |
-11.10% | 3.13B | |
-4.12% | 2.47B | |
+46.46% | 1.96B | |
-7.97% | 1.68B | |
-1.07% | 1.63B | |
-11.56% | 1.56B |